Nerve-Illuminating Agent Shows Early Promise for Reducing Surgical Morbidity



(MedPage Today) — A nerve-illuminating agent to minimize surgical risk passed an early test by achieving sustained fluorescence of the obturator nerve without safety concerns in patients undergoing robotic-assisted prostatectomy.
Intraoperative…



Source link : https://www.medpagetoday.com/hematologyoncology/prostatecancer/116372

Author :

Publish date : 2025-07-02 19:33:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version